A detailed history of Clifford Swan Investment Counsel LLC transactions in Amgen Inc stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 39,722 shares of AMGN stock, worth $12.3 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
39,722
Previous 40,108 0.96%
Holding current value
$12.3 Million
Previous $11.6 Million 2.23%
% of portfolio
0.42%
Previous 0.45%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $103,783 - $125,280
-386 Reduced 0.96%
39,722 $11.3 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $78,499 - $88,557
-307 Reduced 0.76%
40,108 $11.6 Million
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $118,289 - $146,859
-541 Reduced 1.32%
40,415 $10.9 Million
Q2 2023

Aug 03, 2023

SELL
$214.27 - $253.37 $41,354 - $48,900
-193 Reduced 0.47%
40,956 $9.09 Million
Q1 2023

May 05, 2023

SELL
$225.79 - $275.2 $48,544 - $59,168
-215 Reduced 0.52%
41,149 $9.95 Million
Q4 2022

Feb 02, 2023

SELL
$229.03 - $291.01 $916 - $1,164
-4 Reduced 0.01%
41,364 $10.9 Million
Q3 2022

Nov 04, 2022

SELL
$224.46 - $253.15 $57,012 - $64,300
-254 Reduced 0.61%
41,368 $9.32 Million
Q2 2022

Aug 04, 2022

BUY
$230.71 - $256.74 $14,073 - $15,661
61 Added 0.15%
41,622 $10.1 Million
Q1 2022

May 03, 2022

SELL
$219.27 - $242.57 $952,508 - $1.05 Million
-4,344 Reduced 9.46%
41,561 $10.1 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $88,700 - $101,509
-446 Reduced 0.96%
45,905 $10.3 Million
Q3 2021

Nov 02, 2021

SELL
$212.27 - $248.7 $77,478 - $90,775
-365 Reduced 0.78%
46,351 $9.86 Million
Q2 2021

Aug 05, 2021

SELL
$233.58 - $259.14 $392,180 - $435,096
-1,679 Reduced 3.47%
46,716 $10.7 Million
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $258,081 - $300,751
-1,163 Reduced 2.35%
48,395 $12 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $530,131 - $631,291
-2,450 Reduced 4.71%
49,558 $11.4 Million
Q3 2020

Oct 30, 2020

SELL
$234.65 - $260.95 $862,104 - $958,730
-3,674 Reduced 6.6%
52,008 $13.2 Million
Q2 2020

Aug 06, 2020

SELL
$197.81 - $242.74 $137,477 - $168,704
-695 Reduced 1.23%
55,682 $13.1 Million
Q1 2020

Apr 09, 2020

BUY
$182.24 - $241.7 $293,406 - $389,137
1,610 Added 2.94%
56,377 $11.4 Million
Q4 2019

Jan 30, 2020

SELL
$189.21 - $243.2 $218,537 - $280,896
-1,155 Reduced 2.07%
54,767 $13.2 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $16,888 - $20,236
-97 Reduced 0.17%
55,922 $10.8 Million
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $63,846 - $74,842
-383 Reduced 0.68%
56,019 $10.3 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $358,303 - $403,886
-1,981 Reduced 3.39%
56,402 $10.7 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $473,295 - $552,487
-2,653 Reduced 4.35%
58,383 $11.4 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $263,667 - $297,250
-1,423 Reduced 2.28%
61,036 $12.7 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $4,483 - $5,035
-27 Reduced 0.04%
62,459 $11.5 Million
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $64,044 - $74,844
378 Added 0.61%
62,486 $10.7 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $286,099 - $319,660
1,695 Added 2.81%
62,108 $10.8 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $64,406 - $73,535
385 Added 0.64%
60,413 $11.3 Million
Q2 2017

Aug 11, 2017

BUY
N/A
60,028
60,028 $10.3 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $165B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Clifford Swan Investment Counsel LLC Portfolio

Follow Clifford Swan Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.